Table 4 Reported adverse events with AZ vaccine and their correlation with the dose number
From: A 1-year analysis of adverse events following COVID-19 vaccination in Lebanon: a retrospective study
AZ vaccine AEFIs | Dose 1 N = 1997 (%) | Dose 2 N = 164 (%) | p value |
|---|---|---|---|
Systemic AEFIs | |||
 General body pain | 1047 (52.4) | 54 (32.9) | < 0.001* |
 Fatigue | 1152 (57.7) | 68 (41.5) | < 0.001* |
 Headache | 1026 (51.4) | 51 (31.1) | < 0.001* |
 Fever | 958 (48.0) | 44 (26.8) | < 0.001* |
 Chills | 887 (44.4) | 39 (23.8) | < 0.001* |
 Nausea | 470 (23.5) | 25 (15.2) | 0.015* |
 Dyspnea | 180 (9.0) | 15 (9.1) | 0.954 |
 Abdominal pain | 217 (10.9) | 10 (6.1) | 0.056 |
 Diarrhea | 175 (8.8) | 12 (7.3) | 0.527 |
 Cough | 144 (7.2) | 12 (7.3) | 0.960 |
 Dizziness | 106 (5.3) | 7 (4.3) | 0.565 |
 Vomiting | 153 (7.7) | 12 (7.3) | 0.873 |
Local AEFIs | |||
 Injection site pain | 1078 (54.0) | 56 (34.1) | < 0.001* |
 Injection site swelling | 194 (9.7) | 10 (6.1) | 0.128 |
 Injection site erythema | 143 (7.2) | 7 (4.3) | 0.161 |